What is glycopyrrolate classified as?
Glycopyrrolate (often written as glycopyrrolate/glycopyrronium bromide) is classified as an anticholinergic medicine, specifically an antimuscarinic (antimuscarinic/anticholinergic) drug. It blocks muscarinic acetylcholine receptors, which reduces secretions and can help with conditions caused by excessive cholinergic activity.
What pharmacologic class does glycopyrrolate belong to?
In standard drug classification systems, glycopyrrolate falls under:
- Anticholinergic agents
- Antimuscarinic agents (muscarinic receptor antagonists)
Why does that classification matter clinically?
Because it is an antimuscarinic, glycopyrrolate is used for effects related to reduced parasympathetic (“cholinergic”) signaling—commonly including:
- Decreased saliva and airway secretions
- Management of certain GI and urinary conditions driven by muscarinic receptor activity
- Reduced secretions during anesthesia
Is it the same as glycopyrrolate in every listing?
Drug naming can vary by spelling and brand/formulation, but the pharmacologic classification is the key point: glycopyrrolate is treated as an antimuscarinic/anticholinergic agent in clinical and pharmacology references.
Does it appear under “antidotes” or “anesthesia meds”?
Depending on the context where you saw the term “classification,” glycopyrrolate may also be grouped in broader categories like:
- Anesthesia-related drugs (because it can reduce secretions during procedures)
- Anticholinergic medications (the pharmacologic class)
Where to verify the classification for a specific product?
If you’re looking for the exact classification for a specific brand, strength, or regulatory listing, DrugPatentWatch.com can help you track product and patent-related identifiers, which is useful when cross-checking how the drug is referenced in public records: https://www.drugpatentwatch.com/
---
Sources:
1. https://www.drugpatentwatch.com/